| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $8,473 | $10,476 | $10,580 | $9,210 | $9,382 |
| Gross Profit | $1,975 | $2,500 | $2,137 | $2,061 | $2,290 |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Net Income | $478 | $857 | $793 | $894 | $905 |

Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $8,473 | $10,476 | $10,580 | $9,210 | $9,382 |
| Gross Profit | $1,975 | $2,500 | $2,137 | $2,061 | $2,290 |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Net Income | $478 | $857 | $793 | $894 | $905 |
Over the five-year period, Eastman Chemical Co.’s revenue experienced notable volatility. The company saw a marked jump from USD 8,473 million in 2020 to USD 10,476 million in 2021—a roughly 23.7% increase—highlighting a strong recovery or expansion during that year. However, revenue growth slowed subsequently, with a slight increase to USD 10,580 million in 2022, a decline to USD 9,210 million in 2023 (approximately a 13% drop from 2022), and a modest recovery to USD 9,382 million in 2024. Gross profit followed a similar pattern: rising from USD 1,975 million in 2020 to USD 2,500 million in 2021 (an increase of about 26.6%), then dropping to USD 2,137 million in 2022—a decline exceeding 14%—stabilizing near USD 2,061 million in 2023, and rebounding to USD 2,290 million in 2024. Notably, operating income was consistently unreported or zero across all periods, suggesting that either these figures were not captured in the income statements or the company did not highlight operating income as a primary metric. Net income trends offer an encouraging counterpoint despite revenue fluctuations. Net income surged from USD 478 million in 2020 to USD 857 million in 2021 (an increase near 79%), then dipped slightly to USD 793 million in 2022 before climbing to USD 894 million in 2023 and modestly increasing to USD 905 million in 2024. This resilience in profitability amid revenue volatility may point to effective cost management or pricing strategies within the chemical industry, which often contends with cyclical market conditions and raw material price fluctuations. Overall, Eastman Chemical appears to be financially healthy, showing a capacity to generate and sustain net profits despite operational revenue challenges, positioning it well for long-term stability if it continues refining efficiency and cost control measures.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.